Sagimet Biosciences Inc. (SGMT) Operating cash flow 2022–2025
Sagimet Biosciences Inc. (SGMT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$45.6MFY2025 · since FY2022: -$24.5M → -$45.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.6M | -7.6% |
| FY2024 | -$42.4M | -78.6% |
| FY2023 | -$23.8M | +3.0% |
| FY2022 | -$24.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SGMT financial trends
SGMT RevenueSGMT Net incomeSGMT Net marginSGMT Gross profitSGMT Gross marginSGMT Operating incomeSGMT Operating marginSGMT Free cash flowSGMT Capital expendituresSGMT Return on equitySGMT Stock buybacksSGMT Dividends paidSGMT Total assetsSGMT Total liabilitiesSGMT Shareholders’ equitySGMT overview →